These mid-cap plays have reached price levels that could reward shareholders with higher returns than the popular sector fund. …read more
Read more here: 3 Biotech Stocks at Low-Risk Buying Levels
Category: SAGE, CRL, LOXO
Please enter your email to receive banking, savings, mortgage offers and newsletter about the latest financial events.